{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:25:35Z","timestamp":1777904735143,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Sciences Foundation of China","doi-asserted-by":"crossref","award":["82273126"],"award-info":[{"award-number":["82273126"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-025-02179-9","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T01:55:28Z","timestamp":1765245328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multi-dimensional omics integrated machine learning framework identifies macrophage-fibroblast-tumor co-infiltration patterns to predict prognosis in gastric cancer"],"prefix":"10.1038","volume":"9","author":[{"given":"Qi","family":"Wang","sequence":"first","affiliation":[]},{"given":"Yuan","family":"Ni","sequence":"additional","affiliation":[]},{"given":"Sheng","family":"Lu","sequence":"additional","affiliation":[]},{"given":"Benyan","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Jun","family":"Ji","sequence":"additional","affiliation":[]},{"given":"Qu","family":"Cai","sequence":"additional","affiliation":[]},{"given":"Chao","family":"Yan","sequence":"additional","affiliation":[]},{"given":"Feng","family":"Qi","sequence":"additional","affiliation":[]},{"given":"Min","family":"Shi","sequence":"additional","affiliation":[]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"2179_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3322\/caac.21749","volume":"73","author":"JM Foster","year":"2023","unstructured":"Foster, J. M., Zhang, C., Rehman, S., Sharma, P. & Alexander, H. R. The contemporary management of peritoneal metastasis: a journey from the cold past of treatment futility to a warm present and a bright future. CA Cancer J. Clin. 73, 49\u201371 https:\/\/doi.org\/10.3322\/caac.21749 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"2179_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s40265-022-01828-7","volume":"83","author":"NAD Guchelaar","year":"2023","unstructured":"Guchelaar, N. A. D. et al. Intraperitoneal chemotherapy for unresectable peritoneal surface malignancies. Drugs 83, 159\u2013180 https:\/\/doi.org\/10.1007\/s40265-022-01828-7 (2023).","journal-title":"Drugs"},{"key":"2179_CR3","doi-asserted-by":"publisher","first-page":"8073","DOI":"10.1097\/js9.0000000000002090","volume":"110","author":"M Adil","year":"2024","unstructured":"Adil, M. et al. Extensive intraoperative peritoneal lavage with surgery, compared to surgery alone, for patients diagnosed with gastric cancer: a systematic review and meta-analysis of randomized controlled trials. Int J. Surg. 110, 8073\u20138082 https:\/\/doi.org\/10.1097\/js9.0000000000002090 (2024).","journal-title":"Int J. Surg."},{"key":"2179_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","volume":"10","author":"T Yasuda","year":"2024","unstructured":"Yasuda, T. & Wang, Y. A. Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development. Trends Cancer 10, 627\u2013642 https:\/\/doi.org\/10.1016\/j.trecan.2024.03.008 (2024).","journal-title":"Trends Cancer"},{"key":"2179_CR5","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s40265-025-02195-9","volume":"85","author":"PCS Rietveld","year":"2025","unstructured":"Rietveld, P. C. S. et al. A clinical pharmacological perspective on intraperitoneal chemotherapy. Drugs 85, 931\u2013943 https:\/\/doi.org\/10.1007\/s40265-025-02195-9 (2025).","journal-title":"Drugs"},{"key":"2179_CR6","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s10120-025-01631-9","volume":"28","author":"Z Zhu","year":"2025","unstructured":"Zhu, Z. et al. Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasis. Gastric Cancer 28, 731\u2013748 https:\/\/doi.org\/10.1007\/s10120-025-01631-9 (2025).","journal-title":"Gastric Cancer"},{"key":"2179_CR7","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/jco.21.02745","volume":"40","author":"YX Gwee","year":"2022","unstructured":"Gwee, Y. X. et al. Integration of genomic biology into therapeutic strategies of gastric cancer peritoneal metastasis. J. Clin. Oncol. 40, 2830 https:\/\/doi.org\/10.1200\/jco.21.02745 (2022).","journal-title":"J. Clin. Oncol."},{"key":"2179_CR8","doi-asserted-by":"publisher","first-page":"102971","DOI":"10.1016\/j.ctrv.2025.102971","volume":"139","author":"EC Smyth","year":"2025","unstructured":"Smyth, E. C. et al. FGFR2b protein overexpression: an emerging biomarker in gastric and gastroesophageal junction adenocarcinoma. Cancer Treat. Rev. 139, 102971 https:\/\/doi.org\/10.1016\/j.ctrv.2025.102971 (2025).","journal-title":"Cancer Treat. Rev."},{"key":"2179_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41416-024-02717-4","volume":"131","author":"C Ramos","year":"2024","unstructured":"Ramos, C., Gerakopoulos, V. & Oehler, R. Metastasis-associated fibroblasts in peritoneal surface malignancies. Br. J. Cancer 131, 407\u2013419 https:\/\/doi.org\/10.1038\/s41416-024-02717-4 (2024).","journal-title":"Br. J. Cancer"},{"key":"2179_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05205-8","volume":"22","author":"N Dadgar","year":"2024","unstructured":"Dadgar, N. et al. Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis. J. Transl. Med. 22, 402 https:\/\/doi.org\/10.1186\/s12967-024-05205-8 (2024).","journal-title":"J. Transl. Med."},{"key":"2179_CR11","doi-asserted-by":"publisher","first-page":"218012","DOI":"10.1016\/j.canlet.2025.218012","volume":"633","author":"Y Huang","year":"2025","unstructured":"Huang, Y., Zhang, M. & Gao, Q. Mapping the tumor immune landscape: single-cell RNA sequencing in cancer immunotherapy. Cancer Lett. 633, 218012 https:\/\/doi.org\/10.1016\/j.canlet.2025.218012 (2025).","journal-title":"Cancer Lett."},{"key":"2179_CR12","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1021\/jacsau.5c00620","volume":"5","author":"L Zhu","year":"2025","unstructured":"Zhu, L. & Wang, J. Quantifying landscape and flux from single-cell omics: unraveling the physical mechanisms of cell function. JACS Au 5, 3738\u20133757 https:\/\/doi.org\/10.1021\/jacsau.5c00620 (2025).","journal-title":"JACS Au"},{"key":"2179_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/2159-8290.Cd-21-0683","volume":"12","author":"V Kumar","year":"2022","unstructured":"Kumar, V. et al. Single-cell Atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer. Cancer Discov. 12, 670\u2013691 https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-0683 (2022).","journal-title":"Cancer Discov."},{"key":"2179_CR14","doi-asserted-by":"publisher","unstructured":"Zhang, Y. & Liu, Z. Insights into the mechanisms of immune-checkpoint inhibitors gained from spatiotemporal dynamics of the tumor microenvironment. Adv. Sci. e08692. https:\/\/doi.org\/10.1002\/advs.202508692 (2025).","DOI":"10.1002\/advs.202508692"},{"key":"2179_CR15","doi-asserted-by":"publisher","first-page":"104601","DOI":"10.1016\/j.ebiom.2023.104601","volume":"92","author":"Z Li","year":"2023","unstructured":"Li, Z., Wang, J., Wang, Z. & Xu, Y. Towards an optimal model for gastric cancer peritoneal metastasis: current challenges and future directions. EBioMedicine 92, 104601 https:\/\/doi.org\/10.1016\/j.ebiom.2023.104601 (2023).","journal-title":"EBioMedicine"},{"key":"2179_CR16","doi-asserted-by":"publisher","unstructured":"Zhang, J., Che, Y., Liu, R., Wang, Z. & Liu, W. Deep learning-driven multi-omics analysis: enhancing cancer diagnostics and therapeutics. Brief Bioinform. 26, https:\/\/doi.org\/10.1093\/bib\/bbaf440 (2025).","DOI":"10.1093\/bib\/bbaf440"},{"key":"2179_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.5230\/jgc.2025.25.e36","volume":"25","author":"HI Kim","year":"2025","unstructured":"Kim, H. I. & Badgwell, B. D. Peritoneal oligometastasis in gastric cancer: diagnostic strategies, patient selection, and emerging therapeutic approaches. J. Gastric Cancer 25, 409\u2013423 https:\/\/doi.org\/10.5230\/jgc.2025.25.e36 (2025).","journal-title":"J. Gastric Cancer"},{"key":"2179_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1001\/jamasurg.2022.0182","volume":"157","author":"GZ Li","year":"2022","unstructured":"Li, G. Z., Doherty, G. M. & Wang, J. Surgical management of gastric cancer: a review. JAMA Surg. 157, 446\u2013454 https:\/\/doi.org\/10.1001\/jamasurg.2022.0182 (2022).","journal-title":"JAMA Surg."},{"key":"2179_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41572-021-00326-6","volume":"7","author":"D Cort\u00e9s-Guiral","year":"2021","unstructured":"Cort\u00e9s-Guiral, D. et al. Primary and metastatic peritoneal surface malignancies. Nat. Rev. Dis. Prim. 7, 91 https:\/\/doi.org\/10.1038\/s41572-021-00326-6 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2179_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05320-8","volume":"13","author":"H Sun","year":"2022","unstructured":"Sun, H., Wang, X., Wang, X., Xu, M. & Sheng, W. The role of cancer-associated fibroblasts in tumorigenesis of gastric cancer. Cell Death Dis. 13, 874 https:\/\/doi.org\/10.1038\/s41419-022-05320-8 (2022).","journal-title":"Cell Death Dis."},{"key":"2179_CR21","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1038\/s41388-025-03359-3","volume":"44","author":"W Chen","year":"2025","unstructured":"Chen, W. et al. Fibroblast Activation Protein (FAP)(+) cancer-associated fibroblasts induce macrophage M2-like polarization via the Fibronectin 1-Integrin \u03b15\u03b21 axis in breast cancer. Oncogene 44, 2396\u20132412 https:\/\/doi.org\/10.1038\/s41388-025-03359-3 (2025).","journal-title":"Oncogene"},{"key":"2179_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi, J. et al. Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer. Nat. Commun. 13, 1742 https:\/\/doi.org\/10.1038\/s41467-022-29366-6 (2022).","journal-title":"Nat. Commun."},{"key":"2179_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","volume":"9","author":"GQ Zhu","year":"2023","unstructured":"Zhu, G. Q. et al. CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. Cell Discov. 9, 25 https:\/\/doi.org\/10.1038\/s41421-023-00529-z (2023).","journal-title":"Cell Discov."},{"key":"2179_CR24","doi-asserted-by":"publisher","first-page":"4822","DOI":"10.7150\/thno.99046","volume":"14","author":"F Long","year":"2024","unstructured":"Long, F. et al. DAB2 (+) macrophages support FAP (+) fibroblasts in shaping tumor barrier and inducing poor clinical outcomes in liver cancer. Theranostics 14, 4822\u20134843 https:\/\/doi.org\/10.7150\/thno.99046 (2024).","journal-title":"Theranostics"},{"key":"2179_CR25","doi-asserted-by":"publisher","unstructured":"Wang, H. et al. POSTN(+) cancer-associated fibroblasts determine the efficacy of immunotherapy in hepatocellular carcinoma. J. Immunother. Cancer 12, https:\/\/doi.org\/10.1136\/jitc-2023-008721(2024).","DOI":"10.1136\/jitc-2023-008721"},{"key":"2179_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41575-022-00591-0","volume":"19","author":"Y Zavros","year":"2022","unstructured":"Zavros, Y. & Merchant, J. L. The immune microenvironment in gastric adenocarcinoma. Nat. Rev. Gastroenterol. Hepatol. 19, 451\u2013467 https:\/\/doi.org\/10.1038\/s41575-022-00591-0 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2179_CR27","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s10555-021-09991-1","volume":"40","author":"SG Kisling","year":"2021","unstructured":"Kisling, S. G. et al. Implications of prognosis-associated genes in pancreatic tumor metastasis: lessons from global studies in bioinformatics. Cancer Metastasis Rev. 40, 721\u2013738 https:\/\/doi.org\/10.1007\/s10555-021-09991-1 (2021).","journal-title":"Cancer Metastasis Rev."},{"key":"2179_CR28","doi-asserted-by":"publisher","first-page":"115161","DOI":"10.1016\/j.intimp.2025.115161","volume":"162","author":"L Wan","year":"2025","unstructured":"Wan, L. et al. Hypoxia-induced tumor cell-intrinsic PLAU activation drives immunotherapy resistance in collagenic lung adenocarcinoma. Int Immunopharmacol. 162, 115161 https:\/\/doi.org\/10.1016\/j.intimp.2025.115161 (2025).","journal-title":"Int Immunopharmacol."},{"key":"2179_CR29","doi-asserted-by":"publisher","unstructured":"Ferreira, G. M. et al. N-Glycosylation as a key requirement for the positive interaction of integrin and uPAR in glioblastoma. Int. J. Mol. Sci. 26. https:\/\/doi.org\/10.3390\/ijms26115310 (2025).","DOI":"10.3390\/ijms26115310"},{"key":"2179_CR30","doi-asserted-by":"publisher","first-page":"111612","DOI":"10.1016\/j.isci.2024.111612","volume":"28","author":"L Liu","year":"2025","unstructured":"Liu, L. et al. Revealing the role of cancer-associated fibroblast senescence in prognosis and immune landscape in pancreatic cancer. iScience 28, 111612 https:\/\/doi.org\/10.1016\/j.isci.2024.111612 (2025).","journal-title":"iScience"},{"key":"2179_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41368-024-00314-y","volume":"16","author":"M Sun","year":"2024","unstructured":"Sun, M. et al. Cuproptosis-related lncRNA JPX regulates malignant cell behavior and epithelial-immune interaction in head and neck squamous cell carcinoma via miR-193b-3p\/PLAU axis. Int. J. Oral. Sci. 16, 63 https:\/\/doi.org\/10.1038\/s41368-024-00314-y (2024).","journal-title":"Int. J. Oral. Sci."},{"key":"2179_CR32","doi-asserted-by":"publisher","unstructured":"Liu, S. et al. PLAUR(+) Neutrophils Drive Anti-PD-1 therapy resistance in patients with hepatocellular carcinoma by shaping an immunosuppressive microenvironment. Adv. Sci. e07167. https:\/\/doi.org\/10.1002\/advs.202507167 (2025).","DOI":"10.1002\/advs.202507167"},{"key":"2179_CR33","doi-asserted-by":"publisher","first-page":"eabn3774","DOI":"10.1126\/sciadv.abn3774","volume":"8","author":"L Qin","year":"2022","unstructured":"Qin, L. et al. Therapeutic strategies targeting uPAR potentiate anti-PD-1 efficacy in diffuse-type gastric cancer. Sci. Adv. 8, eabn3774 https:\/\/doi.org\/10.1126\/sciadv.abn3774 (2022).","journal-title":"Sci. Adv."},{"key":"2179_CR34","doi-asserted-by":"publisher","first-page":"e1821","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, e1821 https:\/\/doi.org\/10.1016\/j.cell.2019.05.031 (2019).","journal-title":"Cell"},{"key":"2179_CR35","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41587-021-01139-4","volume":"40","author":"V Kleshchevnikov","year":"2022","unstructured":"Kleshchevnikov, V. et al. Cell2location maps fine-grained cell types in spatial transcriptomics. Nat. Biotechnol. 40, 661\u2013671 https:\/\/doi.org\/10.1038\/s41587-021-01139-4 (2022).","journal-title":"Nat. Biotechnol."},{"key":"2179_CR36","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/s41587-022-01233-1","volume":"40","author":"R Wei","year":"2022","unstructured":"Wei, R. et al. Spatial charting of single-cell transcriptomes in tissues. Nat. Biotechnol. 40, 1190\u20131199 https:\/\/doi.org\/10.1038\/s41587-022-01233-1 (2022).","journal-title":"Nat. Biotechnol."},{"key":"2179_CR37","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41592-022-01728-4","volume":"20","author":"Z Cang","year":"2023","unstructured":"Cang, Z. et al. Screening cell-cell communication in spatial transcriptomics via collective optimal transport. Nat. Methods 20, 218\u2013228 https:\/\/doi.org\/10.1038\/s41592-022-01728-4 (2023).","journal-title":"Nat. Methods"},{"key":"2179_CR38","doi-asserted-by":"publisher","unstructured":"Kotliar, D. et al. Identifying gene expression programs of cell-type identity and cellular activity with single-cell RNA-Seq. Elife 8, https:\/\/doi.org\/10.7554\/eLife.43803 (2019).","DOI":"10.7554\/eLife.43803"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02179-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02179-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02179-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:33:15Z","timestamp":1767713595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02179-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2179"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-02179-9","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}